Liver Transplantation for Treatment of Metastatic Neuroendocrine Tumors

Authors


Address for correspondence: Dr. Hakan Ahlman, Department of Surgery and Department of Pathology, Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden. hakan.ahlman@surgery.gu.se

Abstract

Abstract: Liver transplantation can be considered a therapeutic option for patients with neuroendocrine tumors only metastatic to the liver. Important selection criteria are well-differentiated tumors and a low proliferation rate (Ki67 <10%). In this series, orthopic liver transplantation offered good relief of symptoms and long disease-free intervals with initial survival of grafts and patients as in benign disease. The experience with multivisceral transplantation is still limited.

Ancillary